Table 5.
Frequency | Duty Cycle, s (on/off) | Ramp Time | Intensity | Pulse Duration | Waveform/Current | Electrode Size | |
---|---|---|---|---|---|---|---|
Feil et al16 | |||||||
G1 b | 50 | 5/10 | 2 s/1 s down | — | 300-400 μs | — | G1
b
: 10 × 20 cm, 3 × 18 cm, 10 × 7.5 cm, 7 × 14 cm |
G2 c | 50 | 10/20 | 1.5 s/1 s down | — | — | — | G2c: 4 × 70 mm round |
Fitzgerald et al17 | 75 | 10/50 | 2 s up | MT | N/A | 2.5 kHz triangular alternating burst | 6.98 × 12.7 cm |
Lieber et al38 | 50 | 10/20 | 2 s up | MT unadjusted d | 250 μs | Asymmetrical balanced | — |
Sisk et al70 | 40 | 10/30 | 0.5 s up | MT | 300 μs | Rectangular waveform | 5 × 10 cm |
Stevens-Lapsley et al76 | 50 | 15/45 | 3 s up | MT | 250 μs | Symmetrical biphasic | 7.6 × 12.7 cm |
Wigerstad-Lossing et al82 | 30 | 6/10 | 2 s up | MT (65-100 mA) | 300 μs | Rectangular asymmetrical balanced biphasic | 4 × 10 cm |
Williams et al83 | 50 | 15/50 | 3.5 s up | MT | N/A | 2.5 kHz sinusoidal alternating | — |
Yoshida et al84 | |||||||
G1 f | 100 | 10/20 | — | MT e | 1 ms | Symmetrical biphasic | 5 × 9 cm |
G2 g | 100 | Continuous | — | Sensory-level | 1 ms | Symmetrical biphasic | 5 × 9 cm |
MT, maximal tolerance; N/A, not applicable.
“—” indicates information not provided.
Feil et al16: group 1 (G1): Kneehab NMES.
Feil et al16: group 2 (G2): Polystim NMES.
Required to produce visible muscle contraction.
Intensity level was set to maximum toleration during the first treatment setup. This level was then utilized throughout the treatment sessions.
Yoshida et al84: group 1 (G1): motor-level NMES.
Yoshida et al84: group 2 (G2): sensory-level NMES.